Daniel E. Croft

1.1k total citations
18 papers, 789 citations indexed

About

Daniel E. Croft is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel E. Croft has authored 18 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel E. Croft's work include Retinal Diseases and Treatments (13 papers), Retinal and Optic Conditions (10 papers) and Retinal Imaging and Analysis (10 papers). Daniel E. Croft is often cited by papers focused on Retinal Diseases and Treatments (13 papers), Retinal and Optic Conditions (10 papers) and Retinal Imaging and Analysis (10 papers). Daniel E. Croft collaborates with scholars based in United States, France and United Kingdom. Daniel E. Croft's co-authors include Charles C. Wykoff, David M. Brown, Rui Wang, Nizar Saleh Abdelfattah, John F. Payne, Srinivas R. Sadda, Wai T. Wong, Lloyd Clark, William C. Ou and James C. Major and has published in prestigious journals such as Ophthalmology, Investigative Ophthalmology & Visual Science and British Journal of Ophthalmology.

In The Last Decade

Daniel E. Croft

17 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Croft United States 13 767 643 62 42 27 18 789
Bernd A. Kamppeter Germany 16 837 1.1× 563 0.9× 51 0.8× 52 1.2× 30 1.1× 38 864
Matthew M. Wessel United States 5 501 0.7× 404 0.6× 49 0.8× 26 0.6× 11 0.4× 12 558
Akira Ojima Japan 11 854 1.1× 593 0.9× 62 1.0× 20 0.5× 15 0.6× 21 879
Ethan Priel Israel 14 492 0.6× 284 0.4× 49 0.8× 20 0.5× 17 0.6× 21 519
Byung Gil Moon South Korea 10 489 0.6× 444 0.7× 38 0.6× 25 0.6× 29 1.1× 21 514
Mehmet Giray Ersöz Türkiye 14 559 0.7× 440 0.7× 59 1.0× 20 0.5× 52 1.9× 49 592
Nicola Cardascia Italy 13 529 0.7× 294 0.5× 47 0.8× 23 0.5× 31 1.1× 35 546
Christina A. Korb Germany 12 376 0.5× 304 0.5× 45 0.7× 70 1.7× 17 0.6× 32 465
Philip Enders Germany 17 681 0.9× 674 1.0× 49 0.8× 44 1.0× 49 1.8× 60 800
Silvia Bopp Germany 11 334 0.4× 288 0.4× 37 0.6× 20 0.5× 39 1.4× 22 371

Countries citing papers authored by Daniel E. Croft

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Croft more than expected).

Fields of papers citing papers by Daniel E. Croft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Croft. The network helps show where Daniel E. Croft may publish in the future.

Co-authorship network of co-authors of Daniel E. Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Croft. A scholar is included among the top collaborators of Daniel E. Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Croft. Daniel E. Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Brown, David M., William C. Ou, Wai T. Wong, et al.. (2018). Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion. Ophthalmology. 125(5). 683–690. 50 indexed citations
2.
Wykoff, Charles C., William C. Ou, Daniel E. Croft, et al.. (2017). Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. British Journal of Ophthalmology. 102(4). 460–464. 33 indexed citations
3.
Wykoff, Charles C., William C. Ou, David M. Brown, et al.. (2017). Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 1(4). 314–321. 93 indexed citations
4.
Croft, Daniel E., et al.. (2017). Diagnostic and Therapeutic Challenges. Retina. 38(1). 203–206.
5.
Khurana, Rahul N., Charles C. Wykoff, Alok Bansal, et al.. (2016). THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR. Retina. 37(6). 1073–1078. 26 indexed citations
6.
Wykoff, Charles C., David M. Brown, Daniel E. Croft, et al.. (2015). Multicenter, Prospective Trial Comparing Treat & Extend to Monthly Dosing in Neovascular AMD Management: TREX-AMD 12-Month Outcomes. Investigative Ophthalmology & Visual Science. 56(7). 5371–5371. 1 indexed citations
7.
Wang, Rui, Charles C. Wykoff, Daniel E. Croft, et al.. (2015). CHOROIDAL NEOVASCULARIZATION SECONDARY TO ALEXANDRITE LASER EXPOSURE. Retinal Cases & Brief Reports. 10(3). 244–248. 10 indexed citations
8.
Croft, Daniel E., et al.. (2015). Not All Retina Is Created Equal: Metabolic Quantification of Ultra-Widefield Images. Ophthalmology. 122(12). 2580–2582. 6 indexed citations
9.
Wykoff, Charles C., Daniel E. Croft, David M. Brown, et al.. (2015). Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration. Ophthalmology. 122(12). 2514–2522. 221 indexed citations
10.
Major, James C., et al.. (2015). Aflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degeneration. Canadian Journal of Ophthalmology. 50(5). 373–377. 19 indexed citations
11.
Wykoff, Charles C., David M. Brown, Daniel E. Croft, James C. Major, & Wai T. Wong. (2014). PROGRESSIVE RETINAL NONPERFUSION IN ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION. Retina. 35(1). 43–47. 34 indexed citations
12.
Brown, David M., et al.. (2014). RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION. Retina. 34(9). 1728–1735. 76 indexed citations
13.
Wykoff, Charles C., et al.. (2014). Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial). British Journal of Ophthalmology. 98(7). 951–955. 74 indexed citations
14.
Croft, Daniel E., Jano van Hemert, Charles C. Wykoff, et al.. (2014). Precise Montaging and Metric Quantification of Retinal Surface Area From Ultra-Widefield Fundus Photography and Fluorescein Angiography. Ophthalmic surgery, lasers & imaging retina. 45(4). 312–317. 77 indexed citations
15.
16.
Wykoff, Charles C., David M. Brown, Daniel E. Croft, & Wai T. Wong. (2013). Two Year SAVE Outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD. Ophthalmology. 120(9). 1945–1946.e1. 16 indexed citations
17.
Wykoff, Charles C., David M. Brown, Eric Chen, et al.. (2013). SAVE (Super-dose Anti-VEGF) Trial: 2.0 mg Ranibizumab for Recalcitrant Neovascular Age-Related Macular Degeneration: 1-Year Results. Ophthalmic surgery, lasers & imaging retina. 44(2). 121–126. 27 indexed citations
18.
Kalechstein, Ari D., Jin H. Yoon, Daniel E. Croft, et al.. (2011). Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals. Pharmacology Biochemistry and Behavior. 99(3). 423–427. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd A. Kamppeter Breakdown of academic impact, for papers by Matthew M. Wessel Breakdown of academic impact, for papers by Akira Ojima Breakdown of academic impact, for papers by Ethan Priel Breakdown of academic impact, for papers by Byung Gil Moon Breakdown of academic impact, for papers by Mehmet Giray Ersöz Breakdown of academic impact, for papers by Nicola Cardascia Breakdown of academic impact, for papers by Christina A. Korb Breakdown of academic impact, for papers by Philip Enders Breakdown of academic impact, for papers by Silvia Bopp
Rankless by CCL
2026